{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T14:16:24Z","timestamp":1789049784030,"version":"build-2803163510"},"reference-count":10,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2026,5,28]],"date-time":"2026-05-28T00:00:00Z","timestamp":1779926400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,5,28]],"date-time":"2026-05-28T00:00:00Z","timestamp":1779926400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Dig Dis Sci"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1007\/s10620-026-10018-4","type":"journal-article","created":{"date-parts":[[2026,5,28]],"date-time":"2026-05-28T16:38:35Z","timestamp":1779986315000},"page":"4569-4571","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Risk of Autoimmune Hepatitis in Patients with IBD Treated with TNF Antibodies\u2014Which Is Safer?"],"prefix":"10.1007","volume":"71","author":[{"given":"Nai-Yu","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Er-Hsiang","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chiao-Hsiung","family":"Chuang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,28]]},"reference":[{"key":"10018_CR1","doi-asserted-by":"publisher","first-page":"102460","DOI":"10.1016\/j.autrev.2020.102460","volume":"19","author":"O Vollmer","year":"2020","unstructured":"Vollmer O, Felten R, Mertz P, Lebrun-Vignes B, Salem J-E, Arnaud L. Characterization of auto-immune hepatitis associated with the use of anti-TNF\u03b1 agents: an analysis of 389 cases in VigiBase. Autoimmunity Rev 2020;19:102460.","journal-title":"Autoimmunity Rev"},{"key":"10018_CR2","doi-asserted-by":"publisher","first-page":"e39095","DOI":"10.1097\/MD.0000000000039095","volume":"103","author":"RM Dutra","year":"2024","unstructured":"Dutra RM, Pinto FPJ, Craveiro MMS et al. Risks and benefits of anti-TNF therapy for ulcerative colitis in a patient with autoimmune hepatitis-related cirrhosis: case report. Medicine 2024;103:e39095.","journal-title":"Medicine"},{"key":"10018_CR3","doi-asserted-by":"publisher","DOI":"10.1007\/s10620-026-09854-1","author":"H Almusabeh","year":"2026","unstructured":"Almusabeh H, Kovach Z, Lloyd L et al. Risk of autoimmune hepatitis among patients with inflammatory bowel disease treated with infliximab: a retrospective cohort study using a national database. Dig Dis Sci. 2026. https:\/\/doi.org\/10.1007\/s10620-026-09854-1.","journal-title":"Dig Dis Sci"},{"key":"10018_CR4","doi-asserted-by":"publisher","first-page":"758","DOI":"10.1093\/aje\/kwv254","volume":"183","author":"MA Hern\u00e1n","year":"2016","unstructured":"Hern\u00e1n MA, Robins JM. Using big data to emulate a target trial when a randomized trial is not available. Am J Epidemiol 2016;183:758\u2013764.","journal-title":"Am J Epidemiol"},{"key":"10018_CR5","doi-asserted-by":"publisher","first-page":"1002","DOI":"10.1161\/CIRCULATIONAHA.120.051718","volume":"143","author":"JM Franklin","year":"2021","unstructured":"Franklin JM, Patorno E, Desai RJ et al. Emulating randomized clinical trials with nonrandomized real-world evidence studies: first results from the RCT DUPLICATE initiative. Circulation 2021;143:1002\u20131013.","journal-title":"Circulation"},{"key":"10018_CR6","doi-asserted-by":"publisher","first-page":"1695","DOI":"10.1136\/annrheumdis-2014-205318","volume":"73","author":"K Takase","year":"2014","unstructured":"Takase K, Horton SC, Ganesha A et al. What is the utility of routine ANA testing in predicting development of biological DMARD-induced lupus and vasculitis in patients with rheumatoid arthritis? Data from a single-centre cohort. Ann Rheum Dis 2014;73:1695\u20131699.","journal-title":"Ann Rheum Dis"},{"key":"10018_CR7","doi-asserted-by":"publisher","first-page":"602","DOI":"10.1016\/j.cgh.2014.07.062","volume":"13","author":"ES Bj\u00f6rnsson","year":"2015","unstructured":"Bj\u00f6rnsson ES, Gunnarsson BI, Gr\u00f6ndal G et al. Risk of drug-induced liver injury from tumor necrosis factor antagonists. Clin Gastroenterol Hepatol 2015;13:602\u2013608.","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10018_CR8","doi-asserted-by":"publisher","first-page":"s1","DOI":"10.1136\/gutjnl-2024-334395","volume":"74","author":"GW Moran","year":"2025","unstructured":"Moran GW, Gordon M, Sinopolou V et al. British Society of Gastroenterology guidelines on inflammatory bowel disease in adults: 2025. Gut 2025;74:s1\u2013s101.","journal-title":"Gut"},{"key":"10018_CR9","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1093\/ecco-jcc\/jjab178","volume":"16","author":"T Raine","year":"2022","unstructured":"Raine T, Bonovas S, Burisch J et al. ECCO guidelines on therapeutics in ulcerative colitis: medical treatment. J Crohns Colitis 2022;16:2\u201317.","journal-title":"J Crohns Colitis"},{"key":"10018_CR10","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1093\/ecco-jcc\/jjz180","volume":"14","author":"J Torres","year":"2020","unstructured":"Torres J, Bonovas S, Doherty G et al. ecco guidelines on therapeutics in crohn\u2019s disease: medical treatment. J Crohns Colitis 2020;14:4\u201322.","journal-title":"J Crohns Colitis"}],"container-title":["Digestive Diseases and Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10620-026-10018-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10620-026-10018-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10620-026-10018-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T14:01:55Z","timestamp":1789048915000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10620-026-10018-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,28]]},"references-count":10,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2026,10]]}},"alternative-id":["10018"],"URL":"https:\/\/doi.org\/10.1007\/s10620-026-10018-4","relation":{},"ISSN":["0163-2116","1573-2568"],"issn-type":[{"value":"0163-2116","type":"print"},{"value":"1573-2568","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,28]]},"assertion":[{"value":"19 April 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 May 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interest","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This content has been made available to all.","name":"free","label":"Free to read"}]}}